Wound Care (Pharmacies) - Burundi

  • Burundi
  • Revenue in the Wound Care market is projected to reach US$99.43k in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.71%, resulting in a market volume of US$103.00k by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.01 are generated in 2024.

Key regions: China, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care (Pharmacies) market in Burundi is experiencing steady growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Wound Care (Pharmacies) market in Burundi are driving the growth of the industry. Customers in Burundi are increasingly seeking out wound care products from pharmacies due to their convenience and accessibility. Pharmacies provide a one-stop-shop for customers to purchase wound care products, eliminating the need to visit multiple stores. Additionally, customers trust the expertise of pharmacists in recommending the right products for their specific wound care needs. This preference for purchasing wound care products from pharmacies is contributing to the growth of the market in Burundi. Trends in the market are also influencing the development of the Wound Care (Pharmacies) market in Burundi. The market is witnessing a shift towards more advanced wound care products. Customers are increasingly seeking out products that promote faster healing and reduce the risk of infection. This trend is driven by the growing awareness of the importance of proper wound care and the availability of innovative products in the market. As a result, pharmacies in Burundi are expanding their product offerings to meet the demand for these advanced wound care products. Local special circumstances in Burundi are playing a role in the development of the Wound Care (Pharmacies) market. The country has a high prevalence of chronic wounds, which require ongoing care and treatment. This has created a significant demand for wound care products in the market. Additionally, Burundi has a growing elderly population, who are more prone to developing chronic wounds. This demographic factor is further fueling the growth of the Wound Care (Pharmacies) market in Burundi. Underlying macroeconomic factors are also contributing to the growth of the Wound Care (Pharmacies) market in Burundi. The country's healthcare infrastructure is improving, with increased investment in healthcare facilities and services. This has led to better access to healthcare for the population, including wound care services. Additionally, Burundi's economy is growing, leading to higher disposable incomes and increased healthcare spending. As a result, more people in Burundi are able to afford wound care products from pharmacies, driving the growth of the market. In conclusion, the Wound Care (Pharmacies) market in Burundi is developing due to customer preferences for the convenience and expertise offered by pharmacies, trends towards more advanced wound care products, local special circumstances such as a high prevalence of chronic wounds and a growing elderly population, and underlying macroeconomic factors such as improved healthcare infrastructure and growing disposable incomes. This steady growth is expected to continue as the market meets the increasing demand for wound care products in Burundi.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)